Patent Assignment
Reel/Frame 063206/0156
Termination and Release of Security Interest in Intellectual Property at Reel/Frame No. 62452/0106
Recorded: 2023-03-30
Pages: 17
Assignor
B. RILEY COMMERCIAL CAPITAL, LLC, AS ADMINISTRATIVE AGENT
Executed: 2023-03-27
Assignees
HARROW HEALTH, INC.
102 WOODMONT BLVD., SUITE 610, NASHVILLE, TENNESSEE, 37205
HARROW EYE, LLC
102 WOODMONT BLVD., SUITE 610, NASHVILLE, TENNESSEE, 37205
HARROW IP, LLC
102 WOODMONT BLVD., SUITE 610, NASHVILLE, TENNESSEE, 37205
IMPRIMISRX, LLC
1000 AVIARA PARKWAY, SUITE 220, CARLSBAD, CALIFORNIA, 92011
IMPRIMIS NJOF, LLC
1705 ROUTE 46 W, SUITE 6, LEDGEWOOD, NEW JERSEY, 07852
IMPRIMISRX NJ, LLC
1705 ROUTE 46 W, SUITE 4, LEDGEWOOD, NEW JERSEY, 07852
VISIONOLOGY EQUITY, LLC
1000 AVIARA PARKWAY, SUITE 220, CARLSBAD, CALIFORNIA, 92011
VISIONOLOGY, INC.
1000 AVIARA PARKWAY, SUITE 220, CARLSBAD, CALIFORNIA, 92011
VISIONOLOGY MSO, INC.
1000 AVIARA PARKWAY, SUITE 220, CARLSBAD, CALIFORNIA, 92011
Covered Properties
(8)
Topical Nepafenac Formulations
Ophthalmic Compositions Containing a Synergistic Combination of Two Polymers
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
Topical Nepafenac Formulations
Carboxyvinyl Polymer-Containing Nanoparticle Suspensions
Topical Nepafenac Formulations
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
Carboxylvinyl Polymer-Containing Nanoparticle Suspensions
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 3, 2016
From: NOVARTIS AG
To: ALCON RESEARCH LTD.
Reel/Frame 037886/0357 →
Merger
Oct 16, 2019
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 050735/0465 →
Confirmatory Deed of Assignment Effective April 8, 2019
Oct 17, 2019
From: ALCON RESEARCH, LLC
To: NOVARTIS AG
Reel/Frame 050746/0431 →
Corrective Assignment to Correct the Assignee Address. Previously Recorded at Reel: 050746 Frame: 0431. Assignor(S) Hereby Confirms the Assignment..
Oct 18, 2019
From: ALCON RESEARCH, LLC
To: NOVARTIS AG
Reel/Frame 050767/0001 →
Confirmatory Deed of Assignment Effective April 8, 2019
Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
Merger
Dec 11, 2019
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 051257/0562 →
Confirmatory Deed of Assignment Effective April 8, 2019
Dec 14, 2019
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 051293/0444 →
Merger
Jul 21, 2020
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 053273/0022 →
Confirmatory Deed of Assignment Effective April 8, 2019
Jul 23, 2020
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 053293/0484 →
Assignment of Assignor's Interest
Jan 15, 2021
From: ALCON INC.
To: NOVARTIS AG
Reel/Frame 054934/0300 →
Assignment of Assignor's Interest
Jan 20, 2023
From: NOVARTIS AG
To: HARROW IP, LLC
Reel/Frame 062442/0255 →
Security Interest
Jan 23, 2023
From: HARROW HEALTH, INC.; HARROW IP, LLC; IMPRIMISRX, LLC; HARROW EYE, LLC
To: B. RILEY COMMERCIAL CAPITAL, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 062452/0106 →
Patent Security Agreement
Mar 30, 2023
From: HARROW IP, LLC
To: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 063205/0708 →
Release of Security Interest
Sep 18, 2025
From: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
To: HARROW IP, LLC
Reel/Frame 072299/0911 →
Security Interest
Sep 26, 2025
From: HARROW, INC.; HARROW IP, LLC
To: FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 072384/0781 →